Acta Dermato-Venereologica (Jul 2021)

Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use

  • Mette Deleuran,
  • Danielle Marcoux,
  • Marjolein S. Bruin-Weller,
  • Alan D. Irvine,
  • Eulalia Baselga,
  • Kangmo Ahn,
  • Ana Paula Castro,
  • Ashish Bansal,
  • Jingdong Chao,
  • Gaëlle Bégo-Le-Bagousse,
  • Ana B. Rossi

DOI
https://doi.org/10.2340/00015555-3848
Journal volume & issue
Vol. 101, no. 7
p. adv00504

Abstract

Read online

Abstract is missing (Short communication)